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154 lacking various inflammasome proteins. These cells were constructed using the CRISPR-Cas9 155 system and previously used to determine the requirements for human cytomegalovirus (HCMV) 156 inflammasome activation in macrophages [33] . The HUMCYC cell-line (WT) was used to 157 control for any off-target effects of the CRISPR-cas9 system. This line was derived from the 158 same THP-1 cells, but targeted a human pseudogene (HUMCYCPS3). While HSV-1 infection of 159 the WT, AIM2, and IFI16 THP-1 cells led to significant IL-18 production, infection of NLRP3, 160 caspase-1, and ASC cells resulted in levels of IL-18 that were not significantly different from 161 mock infection (Fig 2b) . The combination of nigericin with LPS was used as a positive control. As 162 expected, IL-18 concentrations in supernatants from cells lacking NLRP3, ASC, and caspase-1 163 were not above background after nigericin and LPS exposure. These results indicate that HSV-1 164 induced inflammasome activation with IL-18 production and release in macrophages is 165 dependent on ASC, caspase-1, and NLRP3, but not on the dsDNA sensors IFI16 or AIM2.
167 UV-Irradiated HSV-1 Increases Inflammasome Activation

168
The HSV-1 tegument protein VP22 blocks activation of the AIM2 inflammasome [21] 169 and; therefore, it is unsurprising that we failed to find a dependence on AIM2. However, it is 170 possible that HSV-1 has evolved multiple mechanisms to alter inflammasome activation. To test 171 this hypothesis, we infected M0 and M1 MDMs with HSV-1 or UV irradiated HSV-1 (HSV-1/UV).
172 Interestingly, HSV-1/UV did lead to IL-18 production in M0 macrophages ( Fig. 3a) . This result 173 suggests that M0 macrophages are capable of inflammasome formation in response to HSV-1, 174 but that a viral factor that is produced during the replication cycle (such as VP22) inhibits this 175 activation. When tested in M1 macrophages, HSV-1/UV led to significantly increased IL-18 176 production compared to HSV-1 (Fig 3b) . These data suggest that when macrophages are 177 skewed toward an inflammatory state with IFN, a cellular factor is either produced or 178 upregulated that counteracts the inhibitory mechanism(s) of the virus in M0 macrophages.
179 However, replication of the virus does continue to lead to some downregulation of 180 inflammasome activation in IFN-primed macrophages because HSV-1/UV led to increased IL-18 181 production versus HSV-1. One explanation for this phenomenon is that UV-irradiating the virus 182 eliminates sufficient production of VP22 such that AIM2 is able to sense the viral DNA and 183 trigger inflammasome formation in M0s. Whereas the replication competent virus inhibits 184 AIM2 via VP22, the M0s lack additional factor(s) required to trigger inflammasome signaling in 185 response to HSV-1. After skewing with IFN, HSV-1 infection leads to inflammasome formation 186 through a non-AIM2 dependent mechanism and HSV-1/UV is able to trigger inflammasome 187 signaling through both AIM2 dependent and non-AIM2 dependent mechanisms.
188
To determine if HSV-1 replication in macrophages results in inhibition of any non-AIM2
189 inflammasome proteins, we tested HSV-1/UV infection of the THP-1 cells lacking AIM2 and 190 NLRP3. In order to more closely replicate the MDM model with IFN stimulation, in this 191 experiment the cells were stimulated with PMA and then either infected directly or stimulated 192 with IFN for an additional 24hrs and then infected (Fig 4) . Similar to what was seen in the 193 MDM model, the THP-1 cells that received PMA alone produced only small amounts of IL-18 in 194 response to HSV-1, but significantly more in response to HSV-1/UV. Furthermore, the WT, 195 AIM2, and NLRP3 cells primed with PMA alone all showed a similar increase in IL-18 196 production in response HSV-1/UV compared to replication competent HSV-1 (Fig 4a) .
197 Interestingly, after the addition of IFN, HSV-1 infection led to significant IL-18 production in the . This finding was explained by the discovery that VP22 244 specifically inhibits the interaction between AIM2 and the HSV genome [21] . In agreement with 245 these studies, our current investigation found that AIM2 was not required for HSV-1 to activate 246 the inflammasome in THP-1 cells. Moreover, UV-irradiated HSV-1 led to more IL-18 production, 247 suggesting more robust inflammasome signaling in response to UV-irradiated HSV-1 in both 248 IFN stimulated and unstimulated macrophages. UV-irradiated virus is unable to produce de-249 novo VP22 and therefore the virus is able to activate the inflammasome both through AIM2 and 250 NLRP3. To further support this, while the NLRP3 THP-1 cells did not produce IL-18 in response 251 to HSV-1, they did after UV-irradiating the virus. In this condition, there is insufficient VP22 252 present to inhibit AIM2 and thus the macrophages are able to sense the HSV-1 genome via 253 AIM2. Interestingly, UV-irradiating HSV-1 prior to infection also led to a robust increase in IL-18 254 release in the AIM2 THP-1 cell line compared to WT virus. If the VP22-AIM2 interaction is the 255 only mechanism by which HSV-1 is capable of inhibiting inflammasome activation, we would 256 expect there to be no difference in IL-18 production between AIM2 cells infected with 257 replication competent HSV-1 or UV-irradiated HSV-1 because AIM2 is not present. However, we 258 found that UV-irradiating the virus led to an increase in IL-18 in AIM2 THP-1 cells, suggesting 259 that the virus has evolved other mechanisms to inhibit inflammasome activation in 260 macrophages that are not AIM2 dependent. Having multiple mechanisms of evastion highlights 261 the importance of the role of inflammasome activation in macrophages to control HSV-1.
262
The primary limitation of our study is that it was restricted to primary macrophages and 263 macrophage-like cell lines. As discussed, our data support that HSV-1 is capable of activating 264 more than one inflammasome signaling adapter and the signaling pathway may differ 265 depending on the cell type studied. Therefore, we cannot draw conclusions regarding the 266 interaction between HSV-1 and IFI16 or other inflammasome related proteins in all cell types 267 that the virus is capable of infecting. However, macrophages are a crucial cell type in 268 inflammasome activation and HSV-1 control in murine models, prompting our focus on this cell 269 type. Additionally, the present studies were centered on human cells and cell lines and we did 270 not investigate these inflammasome proteins in other species or whole animal models. A prior 271 study in mice showed that HSV-1 causes more severe keratitis after corneal infection in NLRP3
272 KO mice compared to WT [38] . This suggests that regulation of this pathway is central to the 273 delicate balance between viral control and excessive tissue damage.
274
In summary, we have demonstrated that HSV-1 infection leads to production of IL-18 
